Ophthalmology Canada,
2 year CATT results (Avastin vs Lucentis for wet AMD) published in Ophthalmology today
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Two-Year Results
Overview of attention for article published in Ophthalmology, May 2012
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (97th percentile)
Mentioned by
- news
- 6 news outlets
- blogs
- 1 blog
- policy
- 5 policy sources
- 12 X users
- patent
- 35 patents
- 1 Facebook page
- wikipedia
- 3 Wikipedia pages
- 1 Redditor
- f1000
- 1 research highlight platform
- guideline
- 6 clinical guideline sources
Readers on
- mendeley
- 642 Mendeley